Jump Financial, LLC Axonics, Inc. Transaction History

Jump Financial, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 21, 2024	BUY	$47.99 - $60.21 $51,589 - $64,725	1,075 Added 1.81%	60,363 $3.05 Million
Q2 2023 Aug 07, 2023	BUY	$47.99 - $60.21 $51,589 - $64,725	1,075 Added 1.81%	60,363 $3.05 Million
Q1 2023 Oct 21, 2024	BUY	$52.6 - $67.34 $3.12 Million - $3.99 Million	59,288 New	59,288 $3.23 Million
Q1 2023 May 03, 2023	BUY	$52.6 - $67.34 $1.44 Million - $1.84 Million	27,388 Added 85.86%	59,288 $3.23 Million
Q4 2022 Feb 13, 2023	SELL	$59.56 - $76.6 $821,928 - $1.06 Million	-13,800 Reduced 30.2%	31,900 $1.99 Million
Q3 2022 Nov 07, 2022	BUY	$57.96 - $78.12 $2.65 Million - $3.57 Million	45,700 New	45,700 $3.22 Million
Q4 2021 Feb 10, 2022	SELL	$50.01 - $73.35 $283,206 - $415,381	-5,663 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$59.21 - $78.66 $326,602 - $433,888	-5,516 Reduced 49.34%	5,663 $369,000
Q2 2021 Aug 13, 2021	BUY	$51.39 - $66.9 $574,488 - $747,875	11,179 New	11,179 $709,000
Q1 2021 May 17, 2021	SELL	$49.14 - $59.89 $309,532 - $377,247	-6,299 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$42.19 - $51.5 $548,512 - $669,551	-13,001 Reduced 67.36%	6,299 $314,000
Q3 2020 Nov 13, 2020	BUY	$35.33 - $51.04 $681,869 - $985,072	19,300 New	19,300 $985,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.